Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Damora Therapeutics, Inc. (DMRA)
Waltham, MA, US
Galecto, Inc. is a clinical-stage biotechnology company dedicated to pioneering innovative small molecule therapeutics. These treatments are specifically engineered to address core biological pathways implicated in both cancer and fibrotic disorders. The firm is also actively developing small molecule inhibitors targeting galectin-3 and LOXL2. Established in 2011 by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye, its corporate operations are based in Boston, Massachusetts.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Owner Earnings
Owner's Earnings history not available.
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Virtus Biotech Clinical Trials ETF BBC | 0.85% | 486.5K | 0.65% |
| 2 | Global X - S&P Biotech ETF CURE.AX | 0.19% | 68.1K | 0.45% |
| 3 | State Street SPDR S&P Biotech ETF XBI | 0.19% | 20.45M | 0.35% |
| 4 | Fidelity Fundamental Small-Mid Cap ETF FFSM | 0.07% | 1.02M | 0.43% |
| 5 | iShares Russell 2000 Growth ETF IWO | 0.06% | 9.70M | 0.24% |
| 6 | State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc) R2US.L | 0.05% | 2.79M | 0.30% |
| 7 | Invesco Russell 2000 UCITS ETF RTYS.L | 0.05% | 154.4K | 0.25% |
| 8 | Global X - Russell 2000 ETF RSSL | 0.05% | 708.8K | 0.08% |
| 9 | iShares Russell 2000 BuyWrite ETF IWMW | 0.05% | 27.0K | 0.39% |
| 10 | iShares Russell 2000 ETF IWM | 0.05% | 39.44M | 0.19% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for DMRA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
